Condition: Rheumatoid Arthritis · Sponsor: AstraZeneca
Phase II study in participants with moderately-to-severely active rheumatoid Arthritis (RA) to evaluate efficacy and safety of AZD1163.
This description comes directly from the study's public registry record.
AstraZeneca Clinical Study Information Center · 1-877-240-9479 · information.center@astrazeneca.com
Always discuss trial participation with your own doctor first.
| Research Site | Glendale, Arizona, United States | Not Yet Recruiting |
| Research Site | Prescott Valley, Arizona, United States | Withdrawn |
| Research Site | Tucson, Arizona, United States | Not Yet Recruiting |
| Research Site | La Jolla, California, United States | Not Yet Recruiting |
| Research Site | San Dimas, California, United States | Withdrawn |
| Research Site | San Leandro, California, United States | Not Yet Recruiting |
| Research Site | Aurora, Colorado, United States | Not Yet Recruiting |
| Research Site | Boynton Beach, Florida, United States | Withdrawn |
| Research Site | Jacksonville, Florida, United States | Withdrawn |
| Research Site | South Miami, Florida, United States | Suspended |
| Research Site | Tampa, Florida, United States | Withdrawn |
| Research Site | Winter Haven, Florida, United States | Not Yet Recruiting |
+ 132 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07276581